Roche Holding said its astegolimab drug candidate achieved mixed results in two clinical trials for chronic obstructive ...

Schadenfreude played no small part in turning a video of two Astronomer executives caught in a romantic moment into an online obsession. The low-cost gym giant is coming off four consecutive months of ...

There's a feeling of optimism in the U.S. stock market about the week ahead, with corporate earnings finally poised to hold the spotlight. The European Union still wants a deal, but with U.S. demands ...

Singapore's central bank has appointed three asset managers, including J.P. Morgan Asset Management, as part of its efforts to improve liquidity and trading activity in Southeast Asia's biggest ...

Our fair value estimate for no-moat Region Group is AUD 2.50 per security, derived using a discounted cash flow valuation with a 7.2% weighted average cost of capital. Our valuation implies a ...